A. Manki

Clinical significance of decreased serum concentration of cartilage oligomeric matrix protein in systemic juvenile idiopathic arthritis.

Hiroyuki Tanaka, T. Morishima, Takuya Inoue, 2006, The Journal of rheumatology.

Thalidomide dramatically improves the symptoms of early-onset sarcoidosis/Blau syndrome: its possible action and mechanism.

M. Yashiro, T. Morishima, Kei Takemoto, 2010, Arthritis and rheumatism.

Thalidomide Prevents Formation of Multinucleated Giant Cells (Langhans-Type Cells) from Cultured Monocytes: Possible Pharmaceutical Applications for Granulomatous Disorders

T. Wada, M. Yashiro, K. Yasui, 2009, International journal of immunopathology and pharmacology.

Two cases of chronic active Epstein–Barr virus infection in which EBV‐specific cytotoxic T lymphocyte was induced after allogeneic bone marrow transplantation

K. Yamaguchi, T. Morishima, Toshiaki Ishida, 2008, Pediatric transplantation.

Early-onset sarcoidosis and CARD15 mutations with constitutive nuclear factor-kappaB activation: common genetic etiology with Blau syndrome.

A. Utani, H. Tsutsumi, T. Nakahata, 2004, Blood.

Brief Early-onset sarcoidosis and CARD15 mutations with constitutive nuclear factor- (cid:1) B activation: common genetic etiology with Blau syndrome

A. Utani, H. Tsutsumi, T. Nakahata, 2005 .

Tumor necrosis factor receptor-associated periodic syndrome mimicking systemic juvenile idiopathic arthritis.

T. Morishima, R. Nishikomori, S. Takei, 2006, Allergology international : official journal of the Japanese Society of Allergology.

Proposing a method of regional assessment and a novel outcome measure in rheumatoid arthritis

S. Miyawaki, S. Nishiyama, Y. Yoshinaga, 2012, Rheumatology International.

syndrome B activation: common genetic etiology with Blau κ nuclear factor- Early-onset sarcoidosis and CARD15 mutations with constitutive

A. Utani, H. Tsutsumi, T. Nakahata, 2013 .